Sierra Oncology Stock Price

0.14 (0.93%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sierra Oncology Inc SRRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.14 0.93% 15.14 16:00:05
Open Price Low Price High Price Close Price Previous Close
14.85 14.7401 15.43 15.14 15.00
Bid Price Ask Price Spread News
9.50 18.72 9.22 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
298 10,458 $ 14.95 $ 156,351 15,159 0.2351 - 16.89
Last Trade Time Type Quantity Stock Price Currency
16:00:00 58 $ 15.15 USD

Sierra Oncology Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 167.15M 11.04M 3.83M $ - $ - -30.30 -1.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sierra Oncology News

Date Time Source News Article
11/12/202007:01Edgar (US Regulatory)Current Report Filing (8-k)
11/12/202007:00PR Newswire (Canada)Sierra Oncology to Present at 2020 Jefferies Virtual London..
11/05/202008:00PR Newswire (US)Sierra Oncology to Report Momelotinib Long-term Overall..
11/05/202007:22Edgar (US Regulatory)Quarterly Report (10-q)
11/05/202007:00PR Newswire (Canada)Sierra Oncology Reports Third Quarter 2020 Results
10/19/202016:23Edgar (US Regulatory)Statement of Ownership (sc 13g)
10/02/202007:00PR Newswire (US)Sierra Oncology Announces Inducement Grants Under Nasdaq..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week14.8616.0014.2314.7322,4190.281.88%
1 Month12.2616.0012.2514.1818,6182.8823.49%
3 Months12.1016.0010.0212.2623,0693.0425.12%
6 Months13.5216.0010.0212.6525,1901.6211.98%
1 Year0.2516.890.23510.9847861509,75614.895,956.0%
3 Years2.5516.890.201.46546,31712.59493.73%
5 Years1.5916.890.201.48498,56813.55852.2%

Sierra Oncology Description

Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer in the United States and internationally. The company's lead drug candidate is SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is in Phase 1 clinical trial to treat patients with advanced cancer. In addition, it also engaged in developing SRA141, an orally bioavailable small molecule inhibitor of the cell division cycle 7 kinase that is in the preclinical development stage.
Your Recent History
Sierra Onc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201124 01:04:01